Evidence map›Paper›PMID 40852482›Full record

ArticleFrontiers in oncology2025

Digital pathology-based artificial intelligence model to predict microsatellite instability in gastroesophageal junction adenocarcinomas.

Zhenqian Li, JingQi Chen, Miaomiao Sun, Daoming Li, Kuisheng Chen

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zhenqian LiDepartment of Pathology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
JingQi ChenDepartment of Clinical Medicine, Mudanjiang Medical University, Mudanjiang, China.
Miaomiao SunDepartment of Pathology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Daoming LiDepartment of Pathology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Kuisheng ChenDepartment of Pathology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Microsatellite instability (MSI) plays a crucial role in determining the therapeutic outcomes of gastroesophageal junction (GEJ) adenocarcinoma. This study aimed to develop a deep learning model based on H&E-stained pathological specimens to accurately identify MSI-H in GEJ adenocarcinomas patients. Methods: A total of 416 H&E-stained slides of 212 GEJ adenocarcinoma patients were collected to establish an artificial intelligence (AI) model using digital pathology (DP) for of MSI-H prediction. Simple Vit and ResNet18 Neural networks were trained and tested on models developed from patch-level images. A whole-slide image (WSI)-level AI model was constructed by integrating deep learning- generated pathological features with six machine learning algorithms. Results: The MLP model showed demonstrated the highest performance in predicting MSI-H in the test cohort, achieving an AUC of 93.3%, a sensitivity of 0.841, and a specificity of 0.952. Similarly, Decision Curve Analysis (DCA) revealed that WSI-level H&E-stained slides offered significant clinical MSI-H prediction in GEJ adenocarcinoma patients. Conclusion: The AI model based on digital pathology exhibits great potential for predicting MSI-H in GEJ adenocarcinoma, suggesting promising clinical applications.

Indexed as

artificial intelligencedeep machine learningdigital pathologygastroesophageal junction adenocarcinomasmicrosatellite instabilitymicrosatellite instability high

Identifiers

PMID40852482
PMCPMC12367487

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.